Company news

ENDRA Life Sciences Inc. news in 2026

ENDRA Life Sciences Inc.'s news releases, calls and decks from 2026, newest first.

View company

ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

August 17, 2026

ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing

June 25, 2026

ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS® Liver Imaging Advances and Strategic Review Acceleration Fuels Investor Awareness

May 27, 2026

ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

May 18, 2026

ENDRA Life Sciences Reports Multi-Site Validation of TAEUS(R) Liver Device Demonstrating MRI-like Accuracy and Reproducibility

May 15, 2026

ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility

May 13, 2026

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 30, 2026

ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value

March 24, 2026

ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care

February 25, 2026

Decks in 2026